Home
Market Capitalization of Thyrocare Technologies Ltd

Thyrocare Technologies Ltd
NSE: THYROCARE
Market Cap
Key Highlights
- The Market Cap of Thyrocare Technologies Ltd is ₹ 3853 crore as of 21 Feb 25 .
- The Latest Trading Price of Thyrocare Technologies Ltd is ₹ 727.1 as of 21 Feb 15:30 .
- The Dividend Payouts of Thyrocare Technologies Ltd changed from ₹ 5 on Nov 21, 2019 to ₹ 18 on Aug 16, 2024 . This represents a CAGR of 23.80% over 6 years.

Thyrocare Technologies Ltd
NSE: THYROCARE
Share Price
Market Price of Thyrocare Technologies Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 727.1 |
20 Feb 2025 | 719.55 |
19 Feb 2025 | 716.9 |
18 Feb 2025 | 699.3 |
17 Feb 2025 | 718.45 |
14 Feb 2025 | 721.9 |
13 Feb 2025 | 729.85 |
12 Feb 2025 | 754.65 |
11 Feb 2025 | 747.75 |
10 Feb 2025 | 776.2 |
SWOT Analysis Of Thyrocare Technologies Ltd
BlinkX Score for Thyrocare Technologies Ltd
Asset Value vs Market Value of Thyrocare Technologies Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Thyrocare Technologies Ltd
Historical P/E Ratio of Thyrocare Technologies Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Thyrocare Technologies Ltd
Historical Revenue of Thyrocare Technologies Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Thyrocare Technologies Ltd
Historical EBITDA of Thyrocare Technologies Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Thyrocare Technologies Ltd
Historical Net Profit of Thyrocare Technologies Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Thyrocare Technologies Ltd
Historical Dividend Payouts of Thyrocare Technologies Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payouts of Thyrocare Technologies Ltd
About Thyrocare Technologies Ltd
- Thyrocare Technologies Limited was incorporated in January, 2000.
- The Company operates in the healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India. As of 31 March 2024, the Company offered 929 distinct tests and 90 profiles of tests to detect a number of disorders, including thyroid disorders, growth disorders, metabolism disorders, auto-immunity, diabetes, anemia, cardiovascular disorders, infertility and various infectious diseases.
- Their 43 profiles are administered under its reputed 'Aarogyam' brand, which offers patients a suite of wellness and preventive health care tests.
- The Company primarily operates its testing services through a fully automated Centralised Processing Laboratory (the CPL) and has expanded its operations to include a network of Regional Processing Laboratories (RPLs).
Thyrocare Technologies Ltd News Hub
Thyrocare Technologies AGM scheduled
Thyrocare Technologies announced that the Annual General Meeting (AGM) of the company will be held o
Read more
06 Aug 24
Thyrocare Tech to acquire diagnostic and pathological services of Vimta Lab
Thyrocare Technologies said that it shall have access to 11 centres of Vimta Labs at the locations s
Read more
30 Aug 24
Thyrocare to acquire diagnostic and pathological services of Vimta Lab
Thyrocare Technologies has signed a Business Transfer Agreement for purchase of the diagnostic and p
Read more
30 Aug 24
Thyrocare Technologies announces cessation of director
Thyrocare Technologies announced the cessation of Neetin Shivajirao Desai (DIN No: 02622364) as Inde
Read more
19 Sept 24